Share Capital Disclosure |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2026 | |||||||||||||||||||||||||||||||||||||||||
| Notes | |||||||||||||||||||||||||||||||||||||||||
| Share Capital Disclosure | NOTE 5 - SHARE CAPITAL
During the nine months ended February 28, 2026, the Company issued 750,000 shares valued at $250,000, under an agreement with an investor relations and public relations firm to provide services for an eight-month term, which commenced on March 18, 2025. The total fair value of these shares was measured based on the fair value of the shares issued in accordance with ASC 718, and recognized as part of corporate communications fees included in general and administrative expenses.
Options
As at February 28, 2026 and May 31, 2025, the Company did not have any share purchase options issued and exercisable.
Warrants
The changes in the number of warrants outstanding during the nine months ended February 28, 2026, and for the year ended May 31, 2025, are as follows:
All warrants outstanding at February 28, 2026, were exercisable at $0.75 and expired unexercised on March 12, 2026. |
||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|